Better than an alternative? Probably not. Worth using at all? Sure, if the data supports that conclusion. In particular, a lot of labs have been trying a wide v

Better than an alternative? Probably not. Worth using at all? Sure, if the data supports that conclusion. In particular, a lot of labs have been trying a wide variety of drugs to see if any have efficacy against covid. Ivermectin... just doesn't. Here are three meta-analyses indicating that an SSRI with an expired patent (fluvoxamine) is potentially effective at reducing hospitalization rates for covid: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00448-4/fulltext https://www.thelancet.com/journals/langlo/article/PIIS2214-1... https://www.medrxiv.org/content/10.1101/2021.12.17.21268008v1 https://www.medrxiv.org/content/10.1101/2021.12.17.21268008v... https://pubmed.ncbi.nlm.nih.gov/35118917/ https://pubmed.ncbi.nlm.nih.gov/35118917/